Annals of oncology : official journal of the European Society for Medical Oncology 2022 Mar 14
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
Related Questions
New comment by Medical Oncologist at NYU Winthrop Hospital ( May 11, 2024)
CALOR is an old trial, ER-neg patients benefited from chemotherapy, not ER-positive patients.
Before NGS/PET scans were available.
Now we have better tools for diagnosis and...
New comment by Medical Oncologist at Providence Hood River Memorial Hospital ( May 2, 2024)
I have had the opportunity to care for a few trans and transitioning people in this scenario and have approached it in the same fashion. In all cases, they chose b/l mastectom...